Cargando…
A comprehensive review of COVID-19 symptoms and treatments in the setting of autoimmune diseases
After the first reporting of the index case of Severe Acute Respiratory Syndrome (SARS)-CoV-2-associated disease at the end of December 2019, the virus spread quickly throughout the world, prompting the WHO on 11 March 2020 to declare the disease a global pandemic. The coronavirus disease 2019 (COVI...
Autores principales: | Hamidi, Zahra, Jabraeili-Siahroud, Shaghaiegh, Taati-Alamdari, Yalda, Aghbash, Parisa Shiri, Shamekh, Ali, Baghi, Hossein Bannazadeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9824943/ https://www.ncbi.nlm.nih.gov/pubmed/36611166 http://dx.doi.org/10.1186/s12985-023-01967-7 |
Ejemplares similares
-
SARS-CoV-2 infection: The role of PD-1/PD-L1 and CTLA-4 axis
por: Aghbash, Parisa Shiri, et al.
Publicado: (2021) -
The role of antigen-presenting cells in the pathogenesis of COVID-19
por: Farzi, Rana, et al.
Publicado: (2022) -
SARS-CoV-2: Receptor and Co-receptor Tropism Probability
por: Eslami, Narges, et al.
Publicado: (2022) -
siRNA-E6 sensitizes HPV-16-related cervical cancer through Oxaliplatin: an in vitro study on anti-cancer combination therapy
por: Shiri Aghbash, Parisa, et al.
Publicado: (2023) -
Monoclonal antibodies in cervical malignancy-related HPV
por: Aghbash, Parisa Shiri, et al.
Publicado: (2022)